Retinoids have been the gold standard for treating acne for years, however, many customers with sensitive skin issues (such as rosacea) have a difficult time using the ingredient due to skin irritations including dry skin and redness. To solve this issue, Aklief comes as a new acne cream that contains trifarotene, a new retinoid molecule that is the first new retinoid to be approved by the FDA in 20 years.
Akleif is a topical treatment for acne vulgaris and has been proven to be safe and effective to treat the face, shoulders, back, and chest. The product is more gentle on skin as it "selectively targets the gamma retinoic acid receptor" that "decreases the chance and amount of many of the traditional retinoid side effects like irritation, dryness, and stinging."
Face-and-Body Retinoid Creams
Aklief is a Topical Acne Cream for the Face, Chest, and Back
Trend Themes
1. Sensitive Skin Acne Treatments - Developing acne treatments specifically designed for customers with sensitive skin can provide a disruptive innovation opportunity in the skincare industry.
2. New Retinoid Molecules - Creating new retinoid molecules like trifarotene that are more gentle on the skin can lead to innovative acne treatment solutions.
3. Fda-approved Skincare Ingredients - Continuously researching and developing FDA-approved skincare ingredients can open up new possibilities for effective and safe acne treatments.
Industry Implications
1. Skincare - The skincare industry can explore creating specialized acne treatments that cater to individuals with sensitive skin.
2. Pharmaceutical - The pharmaceutical industry can invest in developing new retinoid molecules to revolutionize acne treatment options.
3. Beauty and Cosmetics - Beauty and cosmetics companies can focus on utilizing FDA-approved ingredients to develop innovative acne treatments for various skin concerns.